Overview

Dose-Dense Therapy in Aggressive Lymphoma

Status:
No longer available

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To investigate if a dose-dense chemotherapy with weekly chemotherapy compared to standard treatment every 3 weeks results in better survival in aggressive non-Hodgkin's lymphoma.

Details

Lead Sponsor:

Arbeitsgemeinschaft medikamentoese Tumortherapie